Understanding the Impact of the New VA Disability Rating Rule on Veterans' Benefits
A recent Department of Veterans Affairs rule that went into effect on February 17 alters how disability ratings are assessed for veterans, focusing on their functionality while on medication rather than the severity of their underlying conditions. The rule applies to all body systems and affects both new claims and existing disabilities up for reevaluation through clinical exams. Public comments on the rule are being accepted until April 20 at regulations.gov under docket RIN 2900-AS49.
The new rule overrides previous court decisions that protected disability ratings from being reduced due to the effects of medication. The VA argues that the rule formalizes longstanding policy and avoids significant disruptions to benefits delivery. However, veterans advocacy organizations like Disabled American Veterans and Veterans of Foreign Wars have expressed concerns about the rule's impact on the millions of veterans receiving disability compensation, especially those who rely on medication to manage their conditions.
Under the new rule, veterans may appear less disabled during evaluations if their symptoms are controlled by medication. This change has raised concerns about the fairness of reevaluations and the potential impact on veterans' benefits. While existing ratings are not automatically changed, any veteran undergoing a scheduled reexamination after February 17 will be evaluated under the new standard. Veterans and organizations can submit public comments on the rule until April 20, and further legislative clarification may be sought to protect veterans' benefits.
It is essential for veterans with pending claims affected by medication effects to seek guidance from accredited veterans service organization representatives or attorneys, as timing may be crucial for cases argued under previous court precedents. Stay informed about changes in military benefits by subscribing to Military.com for the latest updates on pay, health care, and more.